INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹241 Cr | ₹280 Cr | ₹23 Cr | ₹-44 Cr | ₹-30 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹241 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹-44 Cr |
| Mar2021 | ₹-30 Cr |
How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹241 Cr | -13.91 | |
| Mar2024 | ₹280 Cr | 1,129.76 | |
| Mar2023 | ₹23 Cr | Positive | |
| Mar2022 | ₹-44 Cr | Negative | |
| Mar2021 | ₹-30 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,401.2 Cr | 10.3% | 26.6% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 10.3% |
26.6% |
-24.7% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses